Coherus BioSciences Inc Cash Flow-to-Debt Ratio
Coherus BioSciences Inc cash flow-to-debt ratio. Coherus BioSciences Inc (CHRS) has a Cash Flow-to-Debt Ratio of -0.92x as of June 2026, meaning its operating cash flow of $-119.98 Million could theoretically repay -1% of its total liabilities ($130.34 Million) in one year. Check Coherus BioSciences Inc (CHRS) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Coherus BioSciences Inc (2012–2025)
Cash flow-to-debt ratio of Coherus BioSciences Inc from 2012 to 2025. Historical debt coverage capacity for Coherus BioSciences Inc across 14 annual periods. Check how aggressively does Coherus BioSciences Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Coherus BioSciences Inc Cash Flow-to-Debt Ratio by Year (2012–2025)
Coherus BioSciences Inc cash flow-to-debt ratio by year from 2012 to 2025. Year-by-year debt coverage analysis for Coherus BioSciences Inc. For the full cash flow conversion analysis, see cash efficiency ratio of Coherus BioSciences Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.70x | $-138.51 Million | $197.33 Million | ▼ -1893.6% |
| 2024 | -0.04x | $-20.44 Million | $580.52 Million | ▲ +83.4% |
| 2023 | -0.21x | $-174.88 Million | $823.03 Million | ▲ +45.5% |
| 2022 | -0.39x | $-241.12 Million | $618.26 Million | ▼ -506.0% |
| 2021 | -0.06x | $-37.43 Million | $581.61 Million | ▼ -123.4% |
| 2020 | 0.27x | $154.15 Million | $560.67 Million | ▲ +194.5% |
| 2019 | 0.09x | $28.36 Million | $303.71 Million | ▲ +108.1% |
| 2018 | -1.15x | $-159.27 Million | $138.06 Million | ▲ +23.9% |
| 2017 | -1.52x | $-200.29 Million | $132.08 Million | ▲ +4.4% |
| 2016 | -1.59x | $-252.54 Million | $159.13 Million | ▼ -222.3% |
| 2015 | -0.49x | $-107.99 Million | $219.31 Million | ▼ -147.9% |
| 2014 | -0.20x | $-23.93 Million | $120.46 Million | ▼ -215.7% |
| 2013 | 0.17x | $15.42 Million | $89.83 Million | ▲ +116.3% |
| 2012 | -1.05x | $-18.25 Million | $17.34 Million | — |